Ernexa Therapeutics Inc. ( ERNA) - Stock Earnings
ERNA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.5 million USD | — USD |
| 2026Q1 | -5.5 million USD | — USD |
| 2026Q2 | -4.0 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ERNA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -21.7 million USD | 68000 USD |
| 2024 | -44.5 million USD | 582000 USD |
| 2025 | -14.1 million USD | — USD |
| 2026 Est. | — | — |
ERNA
Price: $4.86
52 week price:
Earnings Per Share: -0.41 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 5.0 million